The
synthetic protocols, structural aspects, and spectroscopic
aspects of mononuclear pseudostannatranes possessing a [4.4.3.01,5]tridecane cage have been reported. A tripodal ligand N(CH2CH2OH){CH2(2-t-Bu-4-Me-C6H2OH)}2 (H3L) having unsymmetrical
arms was reacted with n-butyltrichlorostannane, phenyltrichlorostannane,
and tin tetrachloride under different solvent systems to obtain pseudostannatranes
(1–3). The reaction of n-butyltrichlorostannane and the ligand in CH3OH/Na/THF
yielded an aqua complex of pseudostannatrane [LSnBu(H2O)]
(1
a
), which was crystallized
as its acetone solvate (i.e 1
a
·Me2CO). However, the same reactants yielded methanol
complex [LSnBu(CH3OH)] (1
b
) when the reaction was carried out in the NaOCH3/C2H5OH system. Similarly, the reaction of
phenyltrichlorostannane and the ligand under these solvent systems
yielded pseudostannatranes, i.e., an aqua complex [LSnPh(H2O)] (2
a
) and a methanol complex
[LSnPh(CH3OH)] (2
b
) (where 2a
was crystallized as 2
a
·Me2CO). The reaction of
tin tetrachloride and the ligand in the Et3N/THF system
resulted in the formation of pseudostannatrane [LHSnCl2] (3). A similar product was isolated as its triethylamine
solvate (3·NEt
3
) due to the disproportion reaction when PhSnCl3 was reacted
with the ligand in the Et3N/C6H5CH3 system, which demonstrates the first report on the reverse
Kocheshkov reaction in pseudostannatranes. The experimental findings
on the formation of 3·NEt
3
due to the reverse Kocheshkov reaction have been corroborated
with 119Sn NMR spectroscopy and density functional calculations
that provide insightful information about the underlying details of
the reaction route.